Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture |
| June 25, 2021 | June 2021 Bond Updates |
|
SINGAPORE, June 25, 2021 /PRNewswire/ -- CYFIRMA, a threat discovery and cyber-intelligence platform company, funded by Goldman Sachs, Zodius Capital and Z3Partners, today announced that Zuellig Pharma, a leading healthcare services provider in Asia, has selected DeCYFIR, a cloud-based,... |
| View more at: https://www.prnewswire.com:443/news-releases/zuellig-pharma-selects-cyfirma-to-elevate-cyber-intelligence-capabilities-and-strengthen-cybersecurity-posture-301319985.html |
| Related News |